# Oral microbiome dysbiosis in autism spectrum disorder: the oral-gut-brain axis and future perspectives: a narrative review

## TL;DR

This review explores how changes in the oral microbiome might be linked to autism spectrum disorder through the oral-gut-brain axis and highlights potential noninvasive diagnostic tools.

## Contribution

The paper synthesizes recent evidence on oral microbiome alterations in ASD and evaluates their potential impact on neurodevelopmental outcomes.

## Key findings

- Altered oral microbiomes in ASD include increased Streptococcus and decreased Prevotella.
- Oral microbiome changes correlate with clinical symptom severity in ASD.
- Potential biomarkers in the oral microbiome may serve as noninvasive diagnostic tools for ASD.

## Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with a steadily increasing global prevalence, yet its etiology remains largely unclear. Emerging evidence suggests that oral microbiome dysbiosis may contribute to the pathogenesis of ASD, potentially through the oral-gut-brain axis, although the exact role and causality remain to be fully established. In this narrative review, we synthesize recent clinical and metagenomic evidence on oral microbiome alterations in ASD and critically evaluate the potential pathways through which these microbial imbalances may impact neurodevelopmental outcomes. We summarize the key host–microbe interactions, including inflammatory signaling, epithelial barrier disruption, and immune-neural crosstalk, while emphasizing that direct causal evidence is still limited. Dysbiosis in individuals with ASD is characterized by altered microbial communities, including increased Streptococcus and decreased Prevotella, which correlate with clinical symptom severity. Moreover, metagenomic profiling has indicated the presence of potential biomarkers in the oral microbiome, which may serve as promising noninvasive diagnostic tools for ASD. While the clinical applications of oral microbiome diagnostics are still in the early stages, we explore the challenges and opportunities for developing these biomarkers for risk stratification. Finally, we outline future research directions that could enhance the understanding of the oral microbiome’s role in ASD and facilitate the development of personalized intervention strategies.